Federal Diabetes Research Program Yields $50B in Savings, Including Through Medicaid

Avalere estimates that research funded by the Special Diabetes Program has generated over $50 billion in federal healthcare savings through technologies like continuous glucose monitors and automated insulin delivery systems used by Medicare, Medicaid, and VA beneficiaries. The analysis focuses on direct medical cost reductions from improved diabetes management and reduced complications, with Medicaid representing one of three major public payers benefiting from these innovations. The findings have implications for how states and MCOs assess value from diabetes management technologies and clinical interventions.

Managed Care · Finance

This is outside commentary from Avalere, not part of Medicaid Monitor's independently scored news coverage.

More from Avalere